Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CVNA vs GSK✓SelectedUSD · GSKCVNA vs GSK performance historyLatest closeAs of-6.10%11/20
Stock and ETF performance explorer

CVNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+863.9%
GSK return
+53.4%
Excess return
+810.6%
Maximum drawdown
-43.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.1%-0.1%-6.0%-6.1%
7D-11.8%-5.3%-6.4%-11.5%
30D+7.9%-3.7%+11.5%+8.1%
3M-10.7%-7.3%-3.5%-10.4%
6M-1.6%-4.2%+2.6%-1.4%
YTD-24.4%+0.9%-25.2%-23.8%
1Y+1.9%+7.3%-5.4%+2.9%
3Y+863.9%+52.7%+811.2%+739.5%
All+863.9%+53.4%+810.6%+739.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling